|
A male patient underwent aquablation therapy to treat symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation (procept) became aware that, during focal bladder neck cautery (fbnc), the patient sustained a bladder perforation.The treating surgeon indicated that the bladder perforation likely occurred during hemostasis at a thin-walled portion of the diverticulum.The bladder was repaired laparoscopically.No malfunction of the aquabeam robotic system was reported.
|
|
The aquabeam robotic system is a reusable device; therefore, it is currently in the possession of the user facility.The investigation of this event consisted of a review of the device history record (dhr), treatment log files and instructions for use (ifu).A review of the device history record (dhr) for ab2000/serial number (b)(6) was conducted, which confirmed that there were no non conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the device met all design and manufacturing specifications when released for distribution.The aquabeam robotic system's treatment log file was reviewed, which confirmed no malfunctions during the aquablation procedure and indicated that the system functioned as designed.The aquabeam robotic system's instruction for use (ifu) (japan), ifu0107-00, rev.A, was reviewed.4.3 warnings: procedure:
as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include but are not limited to the following, some of which may lead to serious outcomes and may require intervention:
bladder or prostate capsule perforation
based on the information received, plus a review of the treatment log files, dhr, and ifu, the event is considered not to be device related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|